Literature DB >> 12543724

The molecular control of adipogenesis, with special reference to lymphatic pathology.

Evan D Rosen1.   

Abstract

Adipogenesis is the process by which mature fat cells are formed from pre-adipocytes. Adipogenesis has come under increasing scrutiny not only because the availability of reliable in vitro models makes it an attractive choice for developmental studies, but also because adipocytes are increasingly recognized as major players in a variety of physiological and pathophysiological states, such as obesity and type 2 diabetes. Adipocytes develop from mesenchymal stem cell precursors that are characterized by multipotency. Under the influence of various cues, these cells become committed to the adipocyte lineage. Further hormonal stimulation recruits these pre-adipocytes to accumulate lipid, express fat-specific markers, and become sensitive to the metabolic effects of insulin. A complex transcriptional cascade regulates this process, involving several distinct classes of transcription factor. In particular, the role of the nuclear hormone receptor PPARgamma will be discussed, along with bZip family members C/EBPalpha, C/EBPbeta, and C/EBPdelta. The relationship of adipose depots to the lymphatic system will also be discussed.

Entities:  

Mesh:

Year:  2002        PMID: 12543724     DOI: 10.1111/j.1749-6632.2002.tb04875.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  29 in total

1.  c-Abl tyrosine kinase promotes adipocyte differentiation by targeting PPAR-gamma 2.

Authors:  Rom Keshet; Zina Bryansker Kraitshtein; Matan Shanzer; Julia Adler; Nina Reuven; Yosef Shaul
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-03       Impact factor: 11.205

Review 2.  The new era of the lymphatic system: no longer secondary to the blood vascular system.

Authors:  Inho Choi; Sunju Lee; Young-Kwon Hong
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

3.  Krüppel-like factor KLF9 regulates PPARγ transactivation at the middle stage of adipogenesis.

Authors:  H Pei; Y Yao; Y Yang; K Liao; J-R Wu
Journal:  Cell Death Differ       Date:  2010-08-20       Impact factor: 15.828

4.  Platelet factor 4 is a biomarker for lymphatic-promoted disorders.

Authors:  Wanshu Ma; Hyea Jin Gil; Noelia Escobedo; Alberto Benito-Martín; Pilar Ximénez-Embún; Javier Muñoz; Héctor Peinado; Stanley G Rockson; Guillermo Oliver
Journal:  JCI Insight       Date:  2020-07-09

Review 5.  Concise review: adipose-derived stromal vascular fraction cells and platelet-rich plasma: basic and clinical implications for tissue engineering therapies in regenerative surgery.

Authors:  Pietro Gentile; Augusto Orlandi; Maria Giovanna Scioli; Camilla Di Pasquali; Ilaria Bocchini; Valerio Cervelli
Journal:  Stem Cells Transl Med       Date:  2012-02-22       Impact factor: 6.940

Review 6.  What we talk about when we talk about fat.

Authors:  Evan D Rosen; Bruce M Spiegelman
Journal:  Cell       Date:  2014-01-16       Impact factor: 41.582

7.  Association of BTG2, CYR61, ZFP36, and SCD gene polymorphisms with Graves' disease and ophthalmopathy.

Authors:  Tereza Planck; Bushra Shahida; Marketa Sjögren; Leif Groop; Bengt Hallengren; Mikael Lantz
Journal:  Thyroid       Date:  2014-06-03       Impact factor: 6.568

Review 8.  The Lymphatic Vasculature: Its Role in Adipose Metabolism and Obesity.

Authors:  Noelia Escobedo; Guillermo Oliver
Journal:  Cell Metab       Date:  2017-08-24       Impact factor: 27.287

Review 9.  The Lymphatic Vasculature in the 21st Century: Novel Functional Roles in Homeostasis and Disease.

Authors:  Guillermo Oliver; Jonathan Kipnis; Gwendalyn J Randolph; Natasha L Harvey
Journal:  Cell       Date:  2020-07-23       Impact factor: 41.582

10.  Restoration of lymphatic function rescues obesity in Prox1-haploinsufficient mice.

Authors:  Noelia Escobedo; Steven T Proulx; Sinem Karaman; Miriam E Dillard; Nicole Johnson; Michael Detmar; Guillermo Oliver
Journal:  JCI Insight       Date:  2016-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.